Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | GAA | P10253 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.50 |
| ▸ | BLM | P54132 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | GFER | P55789 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | MPO | P05164 | 1/20 | 0.50 |
| ▸ | KDM5A | P29375 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | PEPD | P12955 | 1/20 | 0.45 |
| ▸ | MGLL | Q99685 | 1/20 | 0.45 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.44 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.44 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 4/20 | 0.41 |
| ▸ | CA2 | P00918 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2321477 | 0.82 | MAPT (0.54) | ALDH1A1GAAMGLLCA1CA2 | |
| SCHEMBL2319538 | 0.82 | CA12 (0.52) | ALDH1A1GAAMGLLCA1CA2 | |
| SCHEMBL5443604 | 0.82 | CA12 (0.52) | ALDH1A1GAAMGLLCA1CA2 | |
| SCHEMBL2318554 | 0.82 | L3MBTL1 (0.58) | ALDH1A1GAACYP3A4MGLLERCC1 | |
| SCHEMBL8621971 | 0.80 | ALDH1A1 (0.45) | ALDH1A1GAAMAPK1BLMCYP3A4 | |
| SCHEMBL9364440 | 0.80 | PEPD (0.45) | ALDH1A1GAAMAPK1BLMCYP3A4 | |
| SCHEMBL3659518 | 0.79 | PEPD (0.54) | ALDH1A1GAAMAPK1BLMCYP3A4 | |
| SCHEMBL5438871 | 0.78 | CA1 (0.56) | ALDH1A1GAAGFERMGLLCA1 | |
| SCHEMBL21834459 | 0.78 | ALDH1A1 (0.51) | ALDH1A1GAACYP3A4ERCC1ERCC4 | |
| SCHEMBL30366829 | 0.78 | CA1 (0.56) | ALDH1A1CA1CA2MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12312371-B2 | Optically-active 2-amino-phosphonoalkane acid, optically-active 2-amino-phosphonoalkane acid salt, and hydrates of these | NAHLS CORPORATION CO., LTD. (JP) | 2025-05-27 | — | — | US | claimed |
| EP-3613750-B1 | OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID, OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID SALT, AND HYDRATES OF THESE | UNIV KYOTO (JP) | 2024-12-11 | — | — | EP | claimed |
| CN-110520432-B | Optically active 2-amino-phosphonoalkanoic acid, optically active 2-amino-phosphonoalkanoic acid salt and hydrate thereof | 株式会社NAHLS | 2022-08-02 | — | — | CN | claimed |
| US-11220521-B2 | Optically-active 2-amino-phosphonoalkane acid, optically-active 2-amino-phosphonoalkane acid salt, and hydrates of these | NAHLS CORPORATION CO., LTD. (JP) | 2022-01-11 | — | — | US | claimed |
| US-20200131207-A1 | OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID, OPTICALLY-ACTIVE 2-AMINOPHOSPHONOALKANE ACID SALT, AND HYDRATES OF THESE | NAHLS CORPORATION CO., LTD. (JP) | 2020-04-30 | — | — | US | claimed |
| EP-3613750-A1 | OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID, OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID SALT, AND HYDRATES OF THESE | Kyoto University (JP) | 2020-02-26 | — | — | EP | claimed |
| US-12312371-B2 | Optically-active 2-amino-phosphonoalkane acid, optically-active 2-amino-phosphonoalkane acid salt, and hydrates of these | NAHLS CORPORATION CO., LTD. (JP) | 2025-05-27 | — | — | US | disclosed |
| EP-3613750-B1 | OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID, OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID SALT, AND HYDRATES OF THESE | UNIV KYOTO (JP) | 2024-12-11 | — | — | EP | disclosed |
| EP-3656847-B1 | ADDITIVE COMPOSITION FOR CULTURE MEDIUM, ADDITIVE COMPOUND FOR CULTURE MEDIUM, AND METHOD FOR CULTURE OF CELLS OR TISSUE USING SAME | NISSAN CHEMICAL CORP (JP) | 2022-08-17 | — | — | EP | disclosed |
| CN-110520432-B | Optically active 2-amino-phosphonoalkanoic acid, optically active 2-amino-phosphonoalkanoic acid salt and hydrate thereof | 株式会社NAHLS | 2022-08-02 | — | — | CN | disclosed |
| US-20220135603-A1 | OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID, OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID SALT, AND HYDRATES OF THESE | NAHLS CORPORATION CO., LTD. (JP) | 2022-05-05 | — | — | US | disclosed |
| US-11220521-B2 | Optically-active 2-amino-phosphonoalkane acid, optically-active 2-amino-phosphonoalkane acid salt, and hydrates of these | NAHLS CORPORATION CO., LTD. (JP) | 2022-01-11 | — | — | US | disclosed |
| US-20210253518-A1 | KINASE INHIBITOR | NISSAN CHEMICAL CORPORATION (JP) | 2021-08-19 | — | — | US | disclosed |
| EP-3804707-A1 | KINASE INHIBITOR | Nissan Chemical Corporation (JP) | 2021-04-14 | — | — | EP | disclosed |
| US-20200165194-A1 | ADDITIVE COMPOSITION FOR CULTURE MEDIUM, ADDITIVE COMPOUND FOR CULTURE MEDIUM, AND METHOD FOR CULTURE OF CELLS OR TISSUE USING SAME | NISSAN CHEMICAL CORPORATION (JP) | 2020-05-28 | — | — | US | disclosed |
| US-20200165194-A1 | ADDITIVE COMPOSITION FOR CULTURE MEDIUM, ADDITIVE COMPOUND FOR CULTURE MEDIUM, AND METHOD FOR CULTURE OF CELLS OR TISSUE USING SAME | NISSAN CHEMICAL CORPORATION (JP) | 2020-05-28 | — | — | US | disclosed |
| EP-3656847-A1 | ADDITIVE COMPOSITION FOR CULTURE MEDIUM, ADDITIVE COMPOUND FOR CULTURE MEDIUM, AND METHOD FOR CULTURE OF CELLS OR TISSUE USING SAME | Nissan Chemical Corporation (JP) | 2020-05-27 | — | — | EP | disclosed |
| US-20200131207-A1 | OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID, OPTICALLY-ACTIVE 2-AMINOPHOSPHONOALKANE ACID SALT, AND HYDRATES OF THESE | NAHLS CORPORATION CO., LTD. (JP) | 2020-04-30 | — | — | US | disclosed |
| CN-110945118-A | Composition for adding medium, compound for adding medium, and method for culturing cell or tissue using same | 日产化学株式会社 | 2020-03-31 | — | — | CN | disclosed |
| EP-3613750-A1 | OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID, OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID SALT, AND HYDRATES OF THESE | Kyoto University (JP) | 2020-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220135603-A1 | OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID, OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID SALT, AND HYDRATES OF THESE | AASDHPPT, PHYKPL, PKD2 | ALDH1A1 255/4885GAA 2256/4885MAPK1 718/4885 |
| US-11220521-B2 | Optically-active 2-amino-phosphonoalkane acid, optically-active 2-amino-phosphonoalkane acid salt, and hydrates of these | AASDHPPT, PHYKPL, PKD2 | ALDH1A1 255/4885GAA 2256/4885MAPK1 718/4885 |
| US-20200131207-A1 | OPTICALLY-ACTIVE 2-AMINO-PHOSPHONOALKANE ACID, OPTICALLY-ACTIVE 2-AMINOPHOSPHONOALKANE ACID SALT, AND HYDRATES OF THESE | AASDHPPT, PHYKPL, PHOSPHO1 | ALDH1A1 407/4885GAA 2164/4885MAPK1 829/4885 |
| US-20210253518-A1 | KINASE INHIBITOR | LATS2, LATS1, MAP3K6 | ALDH1A1 3653/4885GAA 1811/4885MAPK1 38/4885 |
| US-20200165194-A1 | ADDITIVE COMPOSITION FOR CULTURE MEDIUM, ADDITIVE COMPOUND FOR CULTURE MEDIUM, AND METHOD FOR CULTURE OF CELLS OR TISSUE USING SAME | NEFM, FGF2, FGF1 | ALDH1A1 1259/4885GAA 4524/4885MAPK1 289/4885 |
| US-12312371-B2 | Optically-active 2-amino-phosphonoalkane acid, optically-active 2-amino-phosphonoalkane acid salt, and hydrates of these | AASDHPPT, PHYKPL, PKD2 | ALDH1A1 255/4885GAA 2256/4885MAPK1 718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.